Your Basket 0

Filter

Applications Product Type Company Conjugate
<<First <Prev    Next> Last>>
Search Results for:
Catalogue No Partner Description Species Application
HY-108831-10mg MedChemexpress LLC Natalizumab [CAS 189261-10-7] COVID-19-immunoregulation
HY-108831-25mg MedChemexpress LLC Natalizumab [CAS 189261-10-7] COVID-19-immunoregulation
HY-108831-5mg MedChemexpress LLC Natalizumab [CAS 189261-10-7] COVID-19-immunoregulation
HY-P99210-1mg MedChemexpress LLC Olokizumab [CAS 1007223-17-7] COVID-19-immunoregulation
HY-P99210-10mg MedChemexpress LLC Olokizumab [CAS 1007223-17-7] COVID-19-immunoregulation
HY-P99210-5mg MedChemexpress LLC Olokizumab [CAS 1007223-17-7] COVID-19-immunoregulation
HY-P990034-1mg MedChemexpress LLC Pateclizumab [CAS 1202526-59-7] COVID-19-immunoregulation
HY-P990034-10mg MedChemexpress LLC Pateclizumab [CAS 1202526-59-7] COVID-19-immunoregulation
HY-P990034-5mg MedChemexpress LLC Pateclizumab [CAS 1202526-59-7] COVID-19-immunoregulation
HY-P99108-1mg MedChemexpress LLC Penpulimab [CAS 2350298-92-7] COVID-19-immunoregulation
HY-P99108-10mg MedChemexpress LLC Penpulimab [CAS 2350298-92-7] COVID-19-immunoregulation
HY-P99108-5mg MedChemexpress LLC Penpulimab [CAS 2350298-92-7] COVID-19-immunoregulation
HY-P9913A-1mg MedChemexpress LLC Rituximab (anti-CD20) [CAS 174722-31-7] COVID-19-immunoregulation
HY-P9913A-25mg MedChemexpress LLC Rituximab (anti-CD20) [CAS 174722-31-7] COVID-19-immunoregulation
HY-P9913A-5mg MedChemexpress LLC Rituximab (anti-CD20) [CAS 174722-31-7] COVID-19-immunoregulation
HY-P9913A-50mg MedChemexpress LLC Rituximab (anti-CD20) [CAS 174722-31-7] COVID-19-immunoregulation
HY-P99267-1mg MedChemexpress LLC Rontalizumab [CAS 948570-30-7] COVID-19-immunoregulation
HY-P99267-10mg MedChemexpress LLC Rontalizumab [CAS 948570-30-7] COVID-19-immunoregulation
HY-P99267-5mg MedChemexpress LLC Rontalizumab [CAS 948570-30-7] COVID-19-immunoregulation
HY-P99895-1mg MedChemexpress LLC Rulonilimab [CAS 2417124-95-7] COVID-19-immunoregulation
HY-P99895-10mg MedChemexpress LLC Rulonilimab [CAS 2417124-95-7] COVID-19-immunoregulation
HY-P99895-5mg MedChemexpress LLC Rulonilimab [CAS 2417124-95-7] COVID-19-immunoregulation
HY-P99112-1mg MedChemexpress LLC Satralizumab [CAS 1535963-91-7] COVID-19-immunoregulation
HY-P99112-10mg MedChemexpress LLC Satralizumab [CAS 1535963-91-7] COVID-19-immunoregulation
HY-P99112-5mg MedChemexpress LLC Satralizumab [CAS 1535963-91-7] COVID-19-immunoregulation
Address

Insight Biotechnology Limited
PO Box 520
Wembley
Middlesex
HA9 7YN
UK

Contact Us

Tel: 0800 073 3133 (UK)
Fax: 0800 953 0268 (UK)
Tel: +44 20 8385 0303 (International)
Email: Info@insightbio.com

Opening Hours

Monday to Friday- 9am- 5pm

Stay Connected!

@InsightBio

Quick Links

About Us>
Contact Us>
FAQs>
Partners>
Special Offers>
Technical Support>

Created by Purplesheep Internet Limited 2024. © Insight biotechnology. All rights reserved.